Literature DB >> 33613676

Comparison of the Modification of Diet in Renal Disease Study and Chronic Kidney Disease Epidemiology Collaboration Equations for Detection of Cardiovascular Risk: Tehran Lipid and Glucose Study.

Pouria Mousapour1, Maryam Barzin1, Majid Valizadeh1, Maryam Mahdavi1, Fereidoun Azizi2, Farhad Hosseinpanah1.   

Abstract

OBJECTIVES: The study aimed to compare the Modification of Diet in Renal Disease Study (MDRD) and the Epidemiology Collaboration (CKD-EPI) equations for the detection of cardiovascular risk.
METHODS: Data of 9,970 Tehranian participants aged ≥ 20 years were analyzed. The prevalence of cardiovascular disease (CVD), its risk factors, and 10-year atherosclerotic cardiovascular disease (ASCVD) risk were compared across the categories of glomerular filtration rate based on the MDRD and CKD-EPI equations. Chronic kidney disease (CKD) was defined as the estimated Glomerular Filtration Rate (eGFR) < 60 mL/min/1.73 m2 according to each equation.
RESULTS: The prevalence of CKD weighted to the 2016 Tehranian urban population was 11.0% (95% confidence interval: 10.3 - 11.6) and 9.7% (9.1 - 10.2) according to the MDRD and CKD-EPI equations, respectively. Besides, 8.3% and 1.5% of the participants with CKDMDRD and non-CKDMDRD were reclassified to non-CKDCKD-EPI and CKDCKD-EPI categories, respectively. Participants with CKDCKD-EPI but without CKDMDRD were more likely to be male and older, and more frequently had diabetes, hypertension, dyslipidemia, and CVD, when compared to those without CKD according to both equations; they were also more likely to be male, older, and smokers, and had less dyslipidemia and more CVD, when compared to those with CKD by using both equations. In multivariate logistic regression analysis, compared to CKDMDRD, the odds of CKDCKD-EPI were significantly higher for older age and lower for the female gender.
CONCLUSIONS: Compared to MDRD, the CKD-EPI equation provides more appropriate detection of cardiovascular risk, which is caused by the reclassification of older individuals and fewer females into lower eGFR categories.
Copyright © 2020, International Journal of Endocrinology and Metabolism.

Entities:  

Keywords:  CKD-EPI Equation; Cardiovascular Cardiovascular Disease; Chronic Kidney Disease; Glomerular Filtration Rate; MDRD Equation

Year:  2020        PMID: 33613676      PMCID: PMC7887458          DOI: 10.5812/ijem.101977

Source DB:  PubMed          Journal:  Int J Endocrinol Metab        ISSN: 1726-913X


  32 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study.

Authors:  Toshiharu Ninomiya; Yutaka Kiyohara; Michiaki Kubo; Yumihiro Tanizaki; Yasufumi Doi; Ken Okubo; Yoshiyuki Wakugawa; Jun Hata; Yoshinori Oishi; Kentaro Shikata; Koji Yonemoto; Hideki Hirakata; Mitsuo Iida
Journal:  Kidney Int       Date:  2005-07       Impact factor: 10.612

3.  Systematic Review and Metaanalysis Comparing the Bias and Accuracy of the Modification of Diet in Renal Disease and Chronic Kidney Disease Epidemiology Collaboration Equations in Community-Based Populations.

Authors:  Emily C McFadden; Jennifer A Hirst; Jan Y Verbakel; Julie H McLellan; F D Richard Hobbs; Richard J Stevens; Chris A O'Callaghan; Daniel S Lasserson
Journal:  Clin Chem       Date:  2017-10-18       Impact factor: 8.327

4.  Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study.

Authors:  Sarah L White; Kevan R Polkinghorne; Robert C Atkins; Steven J Chadban
Journal:  Am J Kidney Dis       Date:  2010-04       Impact factor: 8.860

5.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

6.  Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community.

Authors:  Guruprasad Manjunath; Hocine Tighiouart; Hassan Ibrahim; Bonnie MacLeod; Deeb N Salem; John L Griffith; Josef Coresh; Andrew S Levey; Mark J Sarnak
Journal:  J Am Coll Cardiol       Date:  2003-01-01       Impact factor: 24.094

7.  2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  David C Goff; Donald M Lloyd-Jones; Glen Bennett; Sean Coady; Ralph B D'Agostino; Raymond Gibbons; Philip Greenland; Daniel T Lackland; Daniel Levy; Christopher J O'Donnell; Jennifer G Robinson; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Paul Sorlie; Neil J Stone; Peter W F Wilson
Journal:  J Am Coll Cardiol       Date:  2013-11-12       Impact factor: 24.094

Review 8.  Cardiovascular disease in the Eastern Mediterranean region: epidemiology and risk factor burden.

Authors:  Karam Turk-Adawi; Nizal Sarrafzadegan; Ibtihal Fadhil; Kathryn Taubert; Masoumeh Sadeghi; Nanette K Wenger; Nigel S Tan; Sherry L Grace
Journal:  Nat Rev Cardiol       Date:  2017-09-21       Impact factor: 32.419

9.  Standards of medical care in diabetes-2015 abridged for primary care providers.

Authors: 
Journal:  Clin Diabetes       Date:  2015-04

10.  Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II.

Authors:  Fereidoun Azizi; Arash Ghanbarian; Amir Abbas Momenan; Farzad Hadaegh; Parvin Mirmiran; Mehdi Hedayati; Yadollah Mehrabi; Saleh Zahedi-Asl
Journal:  Trials       Date:  2009-01-25       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.